According to the FDA's official guidance (updated April 2026 at fda.gov), the semaglutide injection shortage was resolved on February 21, 2025, and the transitional exemption windows for compounders operating under the shortage exemption subsequently ended - for 503A pharmacies by April 22, 2025, and for 503B outsourcing facilities by May 22, 2025
Craig Primack, Hims & Hers SVP of Weight Management, joins 'Closing Bell Overtime' to talk the company offering a GLP-1 drug through its platform
Dosing flexibility varies between the two approaches
,
Meat and dairy products and vegetables rich in sulfur generally contain high levels of glutathione
How to save on weight-loss drugs without insurance If your Cigna plan doesnt cover your preferred or prescribed weight-loss drug, talk to your healthcare provider about other alternatives